We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
American Public Education
APEI
$940M
| $736K | ﹤0.01% |
59,893
-92,074
| -61% | -$1.14M |
|
2752
Energy Vault
NRGV
$633M
| $730K | ﹤0.01% |
234,085
+25,682
| +12% | +$95.2K |
|
2753
Cadre Holdings
CDRE
$1.41B
| $728K | ﹤0.01% |
36,134
-11,335
| -24% | -$292K |
|
|
MLNK
2754
DELISTED
MeridianLink
MLNK
| $727K | ﹤0.01% |
52,965
-3,357
| -6% | -$51.8K |
|
|
CTLP
2755
DELISTED
Cantaloupe
CTLP
| $726K | ﹤0.01% |
167,072
-16,240
| -9% | -$57.6K |
|
2756
Solid Power
SLDP
$532M
| $726K | ﹤0.01% |
285,966
-43,461
| -13% | -$186K |
|
2757
Latham Group
SWIM
$880M
| $725K | ﹤0.01% |
225,224
+64,777
| +40% | +$234K |
|
2758
Evolv Technologies
EVLV
$1.1B
| $722K | ﹤0.01% |
278,741
-45,342
| -14% | -$133K |
|
2759
Tarsus Pharmaceuticals
TARS
$2.84B
| $719K | ﹤0.01% |
49,065
-7,953
| -14% | -$132K |
|
|
VLD
2760
DELISTED
Velo3D, Inc.
VLD
| $718K | ﹤0.01% |
11,464
+411
| +4% | +$39.9K |
|
|
HLTH
2761
DELISTED
Cue Health Inc. Common Stock
HLTH
| $714K | ﹤0.01% |
344,956
-40,035
| -10% | -$126K |
|
2762
Heron Therapeutics
HRTX
$92.9M
| $712K | ﹤0.01% |
284,515
-2,765
| -1% | -$8.91K |
|
2763
Organogenesis Holdings
ORGO
$239M
| $712K | ﹤0.01% |
264,545
-120,302
| -31% | -$351K |
|
2764
Future Fuel
FF
$223M
| $711K | ﹤0.01% |
87,393
-20,080
| -19% | -$152K |
|
|
CMRX
2765
DELISTED
Chimerix, Inc.
CMRX
| $699K | ﹤0.01% |
375,766
-64,327
| -15% | -$126K |
|
2766
Ring Energy
REI
$339M
| $689K | ﹤0.01% |
280,301
-235,560
| -46% | -$646K |
|
2767
Motorcar Parts of America
MPAA
$258M
| $688K | ﹤0.01% |
58,016
-9,520
| -14% | -$139K |
|
2768
Fossil Group
FOSL
$318M
| $687K | ﹤0.01% |
159,411
-17,726
| -10% | -$74.1K |
|
2769
Vuzix
VUZI
$224M
| $681K | ﹤0.01% |
187,216
-7,715
| -4% | -$35.3K |
|
2770
Ranpak Holdings
PACK
$473M
| $677K | ﹤0.01% |
117,424
-23,366
| -17% | -$112K |
|
2771
Arbutus Biopharma
ABUS
$915M
| $675K | ﹤0.01% |
290,101
-36,039
| -11% | -$86.2K |
|
|
SRTA
2772
Strata Critical Medical Inc
SRTA
$512M
| $664K | ﹤0.01% |
185,472
-21,601
| -10% | -$92.3K |
|
|
URG
2773
Ur-Energy
URG
$556M
| $662K | ﹤0.01% |
575,962
-16,097
| -3% | -$19.6K |
|
2774
El Pollo Loco
LOCO
$462M
| $632K | ﹤0.01% |
63,464
-89,405
| -58% | -$932K |
|
2775
Cato Corp
CATO
$66.1M
| $631K | ﹤0.01% |
67,699
-10,632
| -14% | -$109K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.